Subscribe to RSS
DOI: 10.1055/s-0038-1652480
Involvement Of Calmodulin In Platelet Reaction
Publication History
Publication Date:
24 July 2018 (online)

Calmodulin is a ubiquitous Ca2+-binding protein, modulating a number of Ca2+-dependent cellular reactions. In blood platelets, involvement of calmodulin has been demonstrated in the activation of myosin light chain kinase and of phospholipase A2. In the present study, involvement of this protein in platelet reaction was thoroughly investigated, utilizing phenothiazines(chlorpromazine and trifluoperazine) known as selective inhibitors of calmodulin.
Phenothiazines in micromolar concentration completely inhibited platelet aggregation and secretion induced by ADP epinephrine, collagen, thrombin or Ca2+-ionophore. They also completely inhibited the aggregation triggered by arachido- nate or by the mixture of thromboxane A2 and prostaglandin endoperoxides, which is probably due to the inhibition of activation of myosin light chain kinase. As another possible involvemnt of calmodulin in the reaction, the effect of phenothiazines on the release of arachidonate from phospholipids was studied in stimulated platelets to which radioactive arachidonate had been incorporated. The release was dose-dependently inhibited by either of phenothiazines. Then, their effect on the hydrolysis of phosphatidylinositol by platelet sonicates was investigated, using 3H-myoinositol phosphatidylinositol as substrate. Either of phenothiazines suppressed the hydrolysis in the micromolar concentration, indicating their inhibition on phosphatidylinositol specific phospholipase C.
These observations suggest involvement of calmodulin in at least two steps of platelt reaction: one is the step of the release of arachidonate from phospholipids (the activation of phospholipase C in addition to phospholipase A2) and the other is the step of contraction of platelet actomyosin after the formation of thromboxane A2 (the activation of myosin light chain kinase).